NeoGenomics has introduced NeoTYPE prognostic panel for detection of mutations in splicing factor 3b subunit 1 (SF3B1) gene of chronic lymphocytic leukemia (CLL) in the US. The CLL Profile panel also includes assays for IgVH mutation ...
Tags: NeoGenomics, prognostic panel, CLL Profile panel, FISH tests
The cancer genetic testing services provider, NeoGenomics has launched the first molecular assay, NeoType CLL for clinical use in the US, which detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1). The assay will offer ...
Tags: molecular assay, clinical research, clinical development